Shire Shares Outstanding 2006-2018 | SHPG

Shire shares outstanding history from 2006 to 2018. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Shire shares outstanding for the quarter ending June 30, 2018 were 0.306B, a 0.53% increase year-over-year.
  • Shire 2017 shares outstanding were 0.304B, a 17.5% increase from 2016.
  • Shire 2016 shares outstanding were 0.259B, a 30.87% increase from 2015.
  • Shire 2015 shares outstanding were 0.198B, a 0.3% increase from 2014.
Shire Annual Shares Outstanding
(Millions of Shares)
2017 304
2016 259
2015 198
2014 197
2013 197
2012 190
2011 198
2010 197
2009 183
2008 182
2007 180
2006 170
2005 167
Shire Quarterly Shares Outstanding
(Millions of Shares)
Q2 2018 306
Q1 2018 304
Q4 2017 304
Q3 2017 304
Q2 2017 304
Q1 2017 304
Q4 2016 259
Q3 2016 300
Q2 2016 228
Q1 2016 198
Q4 2015 198
Q3 2015 198
Q2 2015 198
Q1 2015 198
Q4 2014 197
Q3 2014 198
Q2 2014 197
Q1 2014 196
Q4 2013 197
Q3 2013 195
Q2 2013 195
Q1 2013 176
Q4 2012 190
Q3 2012 198
Q2 2012 198
Q1 2012 192
Q4 2011 198
Q3 2011 594
Q2 2011 595
Q1 2011 594
Q4 2010 197
Q3 2010 557
Q2 2010 590
Q1 2010 586
Q4 2009 183
Q3 2009 548
Q2 2009 181
Q1 2009 577
Q4 2008 182
Q3 2008 540
Q2 2008 543
Q1 2008 582
Q4 2007 180
Q3 2007 555
Q2 2007 547
Q1 2007 530
Q4 2006 170
Q3 2006 509
Q2 2006 510
Q1 2006 510
Q4 2005 167
Q3 2005 501
Q2 2005 500
Q1 2005 501
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $53.681B $15.161B
Shire Pharmaceuticals Group plc is a specialty pharmaceutical company focused primarily on two therapeutic areas: central nervous system disorders and metabolic bone diseases. (press release)
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $44.713B 32.45
Grifols (GRFS) Spain $13.377B 16.33
Tilray (TLRY) United States $11.419B 0.00
Neurocrine Biosciences (NBIX) United States $9.877B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $9.499B 13.98
Nektar Therapeutics (NKTR) United States $6.880B 8.04
Ionis Pharmaceuticals (IONS) United States $6.411B 0.00
Catalent (CTLT) United States $6.001B 25.83
Impax Laboratories (AMRX) United States $5.668B 30.14
Sage Therapeutics (SAGE) United States $5.501B 0.00
United Therapeutics (UTHR) United States $5.326B 6.84
Loxo Oncology (LOXO) United States $4.930B 0.00
FibroGen (FGEN) United States $4.267B 0.00
Endo (ENDP) Ireland $4.044B 5.81
Taro Pharmaceutical Industries (TARO) Israel $3.733B 14.45
Madrigal Pharmaceuticals (MDGL) United States $3.038B 0.00
Aerie Pharmaceuticals (AERI) United States $2.628B 0.00
Ironwood Pharmaceuticals (IRWD) United States $2.585B 0.00
USANA Health Sciences (USNA) United States $2.564B 22.59
Heron Therapeutics (HRTX) United States $2.154B 0.00
TESARO (TSRO) United States $2.027B 0.00
Xencor (XNCR) United States $1.929B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.908B 0.00
PTC Therapeutics (PTCT) United States $1.868B 0.00
Endocyte (ECYT) United States $1.654B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.565B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.508B 18.44
Zogenix (ZGNX) United States $1.496B 0.00
Corcept Therapeutics (CORT) United States $1.401B 21.55
Portola Pharmaceuticals (PTLA) United States $1.388B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.324B 0.00
Tricida (TCDA) United States $1.268B 0.00
Esperion Therapeutics (ESPR) United States $1.259B 0.00
TherapeuticsMD (TXMD) United States $1.243B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.143B 0.00
ImmunoGen (IMGN) United States $0.930B 0.00
Radius Health (RDUS) United States $0.832B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.781B 0.00
Karyopharm Therapeutics (KPTI) United States $0.726B 0.00
Flexion Therapeutics (FLXN) United States $0.651B 0.00
GlycoMimetics (GLYC) United States $0.574B 0.00
Dova Pharmaceuticals (DOVA) United States $0.569B 0.00
ChemoCentryx (CCXI) United States $0.556B 32.53
Collegium Pharmaceutical (COLL) United States $0.548B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.538B 0.00
Dermira (DERM) United States $0.531B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.484B 0.00
Akebia Therapeutics (AKBA) United States $0.473B 0.00
ArQule (ARQL) United States $0.473B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.470B 32.06
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.462B 0.00
Forty Seven (FTSV) United States $0.462B 0.00
OptiNose (OPTN) United States $0.447B 0.00
Xeris Pharmaceuticals (XERS) United States $0.432B 0.00
Minerva Neurosciences (NERV) United States $0.416B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.411B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.407B 0.00
Siga Technologies (SIGA) United States $0.405B 0.00
Odonate Therapeutics (ODT) United States $0.401B 0.00
Aclaris Therapeutics (ACRS) United States $0.388B 0.00
Zafgen (ZFGN) United States $0.381B 0.00
Depomed (ASRT) United States $0.365B 0.00
Synergy Pharmaceuticals (SGYP) United States $0.357B 0.00
Aquestive Therapeutics (AQST) United States $0.352B 0.00
Concert Pharmaceuticals (CNCE) United States $0.347B 0.00
KalVista Pharmaceuticals (KALV) United States $0.346B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.340B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.339B 0.00
ElectroCore (ECOR) United States $0.331B 0.00
Mast Therapeutics (SVRA) United States $0.329B 0.00
Aratana Therapeutics (PETX) United States $0.289B 0.00
Majesco Entertainment (PTE) United States $0.268B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.264B 0.00
IMV INC (IMV) Canada $0.264B 0.00
Translate Bio (TBIO) United States $0.259B 0.00
MEI Pharma (MEIP) United States $0.255B 0.00
CASI Pharmaceuticals (CASI) United States $0.252B 0.00
Aldeyra Therapeutics (ALDX) United States $0.248B 0.00
Tyme Technologies (TYME) United States $0.236B 0.00
Ardelyx (ARDX) United States $0.233B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.233B 0.00
Ocular Therapeutix (OCUL) United States $0.232B 0.00
Opexa Therapeutics (ACER) United States $0.231B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.227B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.215B 0.00
Neon Therapeutics (NTGN) United States $0.215B 0.00
Affimed (AFMD) Germany $0.197B 0.00
Galectin Therapeutics (GALT) United States $0.191B 0.00
Calithera Biosciences (CALA) United States $0.187B 0.00
Achaogen (AKAO) United States $0.180B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.179B 0.00
Jounce Therapeutics (JNCE) United States $0.175B 0.00
Redhill Biopharma (RDHL) Israel $0.175B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.174B 0.00
Melinta Therapeutics (MLNT) United States $0.173B 0.00
Molecular Templates (MTEM) United States $0.170B 0.00
Nature's Sunshine Products (NATR) United States $0.169B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.166B 0.00
MediWound (MDWD) Israel $0.162B 0.00
DURECT (DRRX) United States $0.158B 0.00
Recro Pharma (REPH) United States $0.150B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.149B 0.00
ContraFect (CFRX) United States $0.149B 0.00
Lannett Co Inc (LCI) United States $0.144B 1.20
Adherex Technologies (FENC) United States $0.141B 0.00
Infinity Pharmaceuticals (INFI) United States $0.139B 0.00
Champions Oncology (CSBR) United States $0.136B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.135B 0.00
ProNAi Therapeutics (SRRA) Canada $0.131B 0.00
Neos Therapeutics (NEOS) United States $0.122B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.121B 0.00
Rafael Holdings (RFL) United States $0.114B 0.00
CTI BioPharma (CTIC) United States $0.111B 0.00
Cardiome Pharma (CORV) Canada $0.109B 0.00
Forward Pharma (FWP) Denmark $0.101B 0.00
India Globalization Capital (IGC) United States $0.097B 0.00
BioLineRx (BLRX) Israel $0.096B 0.00
ENTASIS THERAPT (ETTX) United States $0.096B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.085B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.083B 0.00
Iterum Therapeutics (ITRM) Ireland $0.081B 0.00
Immune Design (IMDZ) United States $0.080B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.080B 0.00
Otonomy (OTIC) United States $0.077B 0.00
Natural Alternatives (NAII) United States $0.072B 8.05
Nivalis Therapeutics (ALPN) United States $0.071B 0.00
Novan (NOVN) United States $0.061B 0.00
Genocea Biosciences (GNCA) United States $0.055B 0.00
Trillium Therapeutics (TRIL) Canada $0.051B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.050B 40.24
Capnia (SLNO) United States $0.048B 0.00
Mannatechorporated (MTEX) United States $0.048B 25.05
Ampio Pharmaceuticals (AMPE) United States $0.047B 0.00
SCYNEXIS (SCYX) United States $0.046B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.040B 0.00
KemPharm (KMPH) United States $0.039B 0.00
Heat Biologics (HTBX) United States $0.039B 0.00
Avenue Therapeutics (ATXI) United States $0.036B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.035B 0.00
ProPhase Labs (PRPH) United States $0.034B 3.84
IsoRay (ISR) United States $0.033B 0.00
Xenetic Biosciences (XBIO) United States $0.032B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.032B 0.00
Onconova Therapeutics (ONTX) United States $0.032B 0.00
Biomerica (BMRA) United States $0.029B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.028B 10.05
Jaguar Animal Health (JAGX) United States $0.027B 0.00
Citius Pharmaceuticals (CTXR) United States $0.026B 0.00
Can-Fite Biopharma (CANF) Israel $0.026B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.025B 0.00
HANCOCK JAFFE (HJLI) United States $0.024B 0.00
Lipocine (LPCN) United States $0.024B 0.00
NanoViricides (NNVC) United States $0.023B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.023B 0.00
Aviragen Therapeutics (VXRT) United States $0.022B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.021B 0.00
ESSA Pharma (EPIX) Canada $0.020B 0.00
Aradigm (ARDM) United States $0.019B 0.00
Cyanotech (CYAN) United States $0.019B 0.00
Shineco (TYHT) China $0.018B 1.81
Eyegate Pharmaceuticals (EYEG) United States $0.016B 0.00
Regulus Therapeutics (RGLS) United States $0.016B 0.00
Midatech Pharma (MTP) United Kingdom $0.016B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.015B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.014B 0.00
Skyline Medical (AIPT) United States $0.011B 0.00
OncoGenex Pharmaceuticals (ACHV) United States $0.011B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.009B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.009B 0.00
Pain Therapeutics (PTIE) United States $0.009B 0.00
Apricus Biosciences (APRI) United States $0.007B 0.00
PharmAthene (ALT) United States $0.007B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.007B 0.00
Bio-Path Holdings (BPTH) United States $0.006B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.006B 0.00
Bio Blast Pharma (ORPN) Israel $0.005B 0.00
Intellipharmaceutics (IPCI) Canada $0.003B 0.00
RXi Pharmaceuticals (RXII) United States $0.002B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00